Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
HTML
PDF
Details
Locations
Year:
2018
Type:
review
Source:
Pharmacology & Therapeutics
DOI:
10.1016/j.pharmthera.2018.02.007
Authors:
Andrew M. Kidger,
James Sipthorp,
Simon J. Cook
Institution:
Babraham Institute
Language:
English
Topic:
Melanoma and MAPK Pathways
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
ERK1/2 inhibitor,
Ras signaling,
RAF inhibitors,
MEK inhibitors,
acquired drug resistance,
negative feedback loop,
KRAS amplification,
BRAF amplification,
covalent inhibitors,
combination therapy,
cancer drug targets,
receptor tyrosine kinase
show all 12
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
AstraZeneca,
Astex Pharmaceuticals,
Cancer Research UK,
Biotechnology and Biological Sciences Research Council
Awards:
G2012023987,
Signalling mechanisms that determine the rate of ageing,
G3061974823,
To define the molecular mechanisms that determine cellular and organismal longevity,
G4749662589,
A systems approach to understanding lipid, Ca2+ and MAPK signalling networks
show all 6
OpenAlex ID:
W2789608969
FWCI:
2.138
Cites:
150
Cited by:
180
Related to:
10